دواء الكوليسترول

Berlin – A new oral medication, enalyseted decanoate, is showing remarkable promise in lowering “bad” cholesterol, offering a potential breakthrough for individuals struggling with persistently high levels despite existing treatments. Results from a Phase 3 clinical trial, published recently, indicate the drug can reduce LDL-C – low-density lipoprotein cholesterol – by an average of 58.2% … Read more